Technical Analysis for ABMD - ABIOMED, Inc.

Grade Last Price % Change Price Change
grade F 158.8 -3.93% -6.49
ABMD closed down 3.93 percent on Tuesday, February 25, 2020, on 74 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical ABMD trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
New Downtrend Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Multiple of Ten Bearish Other 0.00%
Outside Day Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Oversold Stochastic Weakness -3.93%
Narrow Range Bar Range Contraction -4.76%
NR7 Range Contraction -4.76%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics; and AbioCor implantable replacement heart. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.
Medicine Medical Specialties Catheter Circulatory System Prosthetics Interventional Cardiology Cardiology Heart Diseases Acute Heart Failure Heart Attack

Is ABMD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 352.87
52 Week Low 155.02
Average Volume 919,077
200-Day Moving Average 207.04
50-Day Moving Average 176.83
20-Day Moving Average 177.21
10-Day Moving Average 167.06
Average True Range 7.38
ADX 25.73
+DI 13.69
-DI 33.81
Chandelier Exit (Long, 3 ATRs ) 177.12
Chandelier Exit (Short, 3 ATRs ) 180.03
Upper Bollinger Band 199.57
Lower Bollinger Band 154.85
Percent B (%b) 0.09
BandWidth 25.24
MACD Line -5.06
MACD Signal Line -3.14
MACD Histogram -1.9202
Fundamentals Value
Market Cap 7.01 Billion
Num Shares 44.1 Million
EPS 1.71
Price-to-Earnings (P/E) Ratio 92.87
Price-to-Sales 16.68
Price-to-Book 13.96
PEG Ratio 2.75
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 172.46
Resistance 3 (R3) 173.67 170.34 170.18
Resistance 2 (R2) 170.34 166.86 169.73 169.42
Resistance 1 (R1) 164.57 164.71 162.90 163.35 168.66
Pivot Point 161.23 161.23 160.40 160.62 161.23
Support 1 (S1) 155.46 157.75 153.79 154.25 148.94
Support 2 (S2) 152.13 155.60 151.52 148.18
Support 3 (S3) 146.36 152.13 147.42
Support 4 (S4) 145.14